The Immune Tolerance Network (ITN) has announced a new clinical research fellowship program that will provide promising junior-level faculty with intensive, hands-on training in the planning, design ...

Genesis Research Group, a pioneer of tech-enabled real-world evidence (RWE), health economics and outcomes research (HEOR), and market access services, announces the participation of its CEO David W.

Genesis Research Group, led by newly appointed CEO, David W. Miller, is spotlighted in June’s launch of ITN Business’ “Advancing Healthcare” program for its ‘innovate differently’ approach to ...

Genesis Research Group Announces Participation of CEO David W. Miller in New ITN Business Healthcare Program Genesis Research Group, led by newly appointed CEO, David W. Miller, is spotlighted in June ...